Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Hormone levels studied are not linked to PCOS.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

Females with idiopathic hirsutism have higher levels of omentin-1, which may lead to excessive hair growth.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Amla oil may help treat hair loss.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

Ring Chromosome 11 may be linked to conditions like early puberty, excessive hair growth, hair loss, and type 2 diabetes.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Hirsutism in young girls can have causes other than PCOS, so diagnoses should be reassessed if treatments don't work.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Bioactive compounds in neurocosmetics can improve skin health and emotional well-being.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.